Friday, April 3, 2026
30.4 C
Bengaluru

Winning Sales Organization

[wpfilebase tag=file id=101 tpl=download-button /]

Inside this Issue

1. Rudyard Kipling and the Pharma Brand Plan  by  Vivek Hattangadi

The wisdom of the renown English poet applied to pharma brand planning

2. What Does Digitilization Mean to You? by Hanno Wolfram

A look at the impact of digital at every step of the healthcare value chaint 

3. Selling in a Digital Era by Salil Kallianpuri

The right message, to the right customer, at the right frequency, through the right channels 

4. OPPI 51 AGM Highlights  by K. Hariram

Reporting

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of November 2017

Download the issue here: PDF

Hot this week

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...
spot_img

Related Articles

spot_imgspot_img